Enterprise Value
0.00
Cash
31.61M
Avg Qtr Burn
N/A
Short % of Float
5.30%
Insider Ownership
0.35%
Institutional Own.
82.85%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HPN536 (MSLN) Details Ovarian cancer, Solid tumor/s, Pancreatic cancer | Failed Discontinued | |
HPN424 (PSMA and CD3) Details Prostate cancer | Failed Discontinued |